Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Lang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cell|May 18, 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceSandhya Bangaru, Shanshan Lang, Michael Schotsaert, et al.
Cancer Research|March 16, 2022
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell CarcinomaSiler H Panowski, Surabhi Srinivasan, Nguyen Tan, et al.
Nature Communications|July 12, 2018
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HASandhya Bangaru, Heng Zhang, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Nature|March 19, 2026
In vivo site-specific engineering to reprogram T cellsWilliam A Nyberg, Pierre-Louis Bernard, Wayne Ngo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cell|May 18, 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceSandhya Bangaru, Shanshan Lang, Michael Schotsaert, et al.
Cancer Research|March 16, 2022
Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell CarcinomaSiler H Panowski, Surabhi Srinivasan, Nguyen Tan, et al.
Nature Communications|July 12, 2018
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HASandhya Bangaru, Heng Zhang, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Nature|March 19, 2026
In vivo site-specific engineering to reprogram T cellsWilliam A Nyberg, Pierre-Louis Bernard, Wayne Ngo, et al.
Pageof 2